author-photo

Kazuhiro Kitamura

Nippon Medical School

12

Papers

484

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

2015 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 5206: Mir-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation.

2013 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (37)
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion

2013 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (33)
Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules

2012 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Abstract 5548: High copy number of the MET gene predicts resistance to EGFR-TKI in non-small cell lung cancer patients.

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner

2010 Oncology Letters
Show All
- Source
- Cite
- Save
Citations (22)
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer

2009 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)